Curcumin inhibits mitochondrial injury and apoptosis from the early stage in EAE mice

Oxidative Medicine and Cellular Longevity

Volumn 2014, Issue , 2014, Pages

  Feng, Jinzhou ^a   Tao, Tao ^b   Yan, Weiping ^a   Chen, Cindy Si ^c   Qin, Xinyue ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b SOUTHWEST MEDICAL UNIVERSITY   (China)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DEATH; MAMMALS;

APOPTOTIC CELLS; APOPTOTIC PATHWAYS; NEURONAL CELL; OLIGODENDROCYTES; PATHOPHYSIOLOGICAL CHANGES; SPINAL CORDS; TIME POINTS; UP-REGULATION;

MITOCHONDRIA;

CASPASE 3; CASPASE 9; CURCUMIN; CYTOCHROME C;

ANIMAL; APOPTOSIS; C57BL MOUSE; CYTOLOGY; DRUG EFFECTS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; METABOLISM; MITOCHONDRION; MOUSE; OLIGODENDROGLIA; PATHOLOGY; UPREGULATION;

ANIMALS; APOPTOSIS; CASPASE 3; CASPASE 9; CURCUMIN; CYTOCHROMES C; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; MICE; MICE, INBRED C57BL; MITOCHONDRIA; OLIGODENDROGLIA; UP-REGULATION;

EID: 84901290763     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2014/728751     Document Type: Article

References (26)

1. O'Connor K. C., Bar-Or A., Hafler D. A., The neuroimmunology of multiple sclerosis: possible roles of T and B lymphocytes in immunopathogenesis. Journal of Clinical Immunology 2001 21 2 81 92 2-s2.0-0035044638 10.1023/A:1011064007686 (Pubitemid 32328759)
2. Barnett M. H., Prineas J. W., Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Annals of Neurology 2004 55 4 458 468 2-s2.0-1642281535 10.1002/ana.20016 (Pubitemid 38391962)
3. Barnett M. H., Henderson A. P. D., Prineas J. W., The macrophage in MS: just a scavenger after all? Pathology and pathogenesis of the acute MS lesion. Multiple Sclerosis 2006 12 2 121 132 2-s2.0-33645807860 10.1191/ 135248506ms1304rr
4. Henderson A. P. D., Barnett M. H., Parratt J. D. E., Prineas J. W., Multiple sclerosis: distribution of inflammatory cells in newly forming lesions. Annals of Neurology 2009 66 6 739 753 2-s2.0-73549089256 10.1002/ana.21800
5. Rice C. M., Sun M., Kemp K., Gray E., Wilkins A., Scolding N. J., Mitochondrial sirtuins-a new therapeutic target for repair and protection in multiple sclerosis. European Journal of Neuroscience 2012 35 12 1887 1893 10.1111/j.1460-9568.2012.08150.x
6. Campbell G. R., Mahad D. J., Clonal expansion of mitochondrial DNA deletions and the progression of multiple sclerosis. CNS & Neurological Disorders Drug Targets 2012 11 5 589 597 10.2174/187152712801661194
7. van Horssen J., Witte M. E., Ciccarelli O., The role of mitochondria in axonal degeneration and tissue repair in MS. Multiple Sclerosis 2012 18 8 1058 1067 10.1177/1352458512452924
8. Kanakasabai S., Casalini E., Walline C. C., Mo C., Chearwae W., Bright J. J., Differential regulation of CD4+ T helper cell responses by curcumin in experimental autoimmune encephalomyelitis. Journal of Nutritional Biochemistry 2012 23 11 1498 1507 2-s2.0-84857666554 10.1016/j.jnutbio.2011.10.002
9. Zhuang X., Xiang X., Grizzle W., Sun D., Zhang S., Axtell R. C., Ju S., Mu J., Zhang L., Steinman L., Miller D., Zhang H., Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Molecular Therapy 2011 19 10 1769 1779 2-s2.0-80053574021 10.1038/mt.2011.164
10. Verhagen J., Burton B. R., Britton G. J., Shepard E. R., Anderton S. M., Wraith D. C., Modification of the FoxP3 transcription factor principally affects inducible T regulatory cells in a model of experimental autoimmune encephalomyelitis. PLoS ONE 2012 8 4 e61334
11. Feng J., Zhang G., Hu X., Si Chen C., Qin X., Estrogen inhibits estrogen receptor alpha-mediated Rho-kinase expression in experimental autoimmune encephalomyelitis rats. Synapse 2013 67 7 399 406
12. Xie L., Li X., Funeshima-Fuji N., Kimura H., Matsumoto Y., Isaka Y., Takahara S., Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of IL-17 production. International Immunopharmacology 2009 9 5 575 581 2-s2.0-63549122337 10.1016/j.intimp.2009.01. 025
13. You W. C., Wang C. X., Pan Y. X., Activation of nuclear factor-kappaB in the brain after experimental subarachnoid hemorrhage and its potential role in delayed brain injury. PLoS ONE 2013 8 3 e60290
14. Zhan X., Pongstaporn T., Ryugo D. K., Projections of the second cervical dorsal root ganglion to the cochlear nucleus in rats. Journal of Comparative Neurology 2006 496 3 335 348 2-s2.0-33645687422 10.1002/cne.20917
15. Xia Y. H., Wang Z. M., Chen R. X., T-cell apoptosis induced by intratumoral activated hepatic stellate cells is associated with lung metastasis in hepatocellular carcinoma. Oncology Reports 2013
16. Tu Y. F., Lu P., Huang C., Ho C., Chou Y., Moderate dietary restriction reduces p53-mediated neurovascular damage and microglia activation after hypoxic ischemia in neonatal brain. Stroke 2012 43 2 491 498 2-s2.0-84856465979 10.1161/STROKEAHA.111.629931
17. Mahad D., Ziabreva I., Lassmann H., Turnbull D., Mitochondrial defects in acute multiple sclerosis lesions. Brain 2008 131 7 1722 1735 2-s2.0-46849122006 10.1093/brain/awn105 (Pubitemid 351957459)
18. Orrenius S., Gogvadze V., Zhivotovsky B., Mitochondrial oxidative stress: implications for cell death. Annual Review of Pharmacology and Toxicology 2007 47 143 183 2-s2.0-33847045900 10.1146/annurev.pharmtox.47.120505.105122
19. Chearwae W., Bright J. J., 15-Deoxy-Δ12,14-prostaglandin J2 and curcumin modulate the expression of toll-like receptors 4 and 9 in autoimmune T lymphocyte. Journal of Clinical Immunology 2008 28 5 558 570 2-s2.0-51349104881 10.1007/s10875-008-9202-7
20. Natarajan C., Bright J. J., Curcumin inhibits experimental allergic encephalomyelitis by blocking IL-12 signaling through Janus kinase-STAT pathway in T lymphocytes. Journal of Immunology 2002 168 12 6506 6513 2-s2.0-0037097660 (Pubitemid 34620077)
21. Liu Y., He P., Zhang M., Wu D., Lentiviral vector-mediated RNA interference targeted against prohibitin inhibits apoptosis of the retinoic acid-resistant acute promyelocytic leukemia cell line NB4-R1. Molecular Medicine Reports 2012 6 6 1288 1292
22. Caroppi P., Sinibaldi F., Fiorucci L., Santucci R., Apoptosis and human diseases: mitochondrion damage and lethal role of released cytochrome c as proapoptotic protein. Current Medicinal Chemistry 2009 16 31 4058 4065 2-s2.0-70450205079 10.2174/092986709789378206
23. Hüttemann M., Pecina P., Rainbolt M., Sanderson T. H., Kagan V. E., Samavati L., Doan J. W., Lee I., The multiple functions of cytochrome c and their regulation in life and death decisions of the mammalian cell: from respiration to apoptosis. Mitochondrion 2011 11 3 369 381 2-s2.0-79953745644 10.1016/j.mito.2011.01.010
24. Kilbride S. M., Prehn J. H., Central roles of apoptotic proteins in mitochondrial function. Oncogene 2013 32 22 2703 2711 10.1038/onc.2012.348
25. Kulikov A. V., Shilov E. S., Mufazalov I. A., Gogvadze V., Nedospasov S. A., Zhivotovsky B., Cytochrome c: the Achilles' heel in apoptosis. Cellular and Molecular Life Sciences 2012 69 11 1787 1797
26. Allan L. A., Clarke P. R., Apoptosis and autophagy: regulation of caspase-9 by phosphorylation. FEBS Journal 2009 276 21 6063 6073 2-s2.0-70349956567 10.1111/j.1742-4658.2009.07330.x